» Articles » PMID: 26756023

When Anti-Aging Studies Meet Cancer Chemoprevention: Can Anti-Aging Agent Kill Two Birds with One Blow?

Overview
Date 2016 Jan 13
PMID 26756023
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Recent evidence has strongly supported that the rate of aging is controlled, at least to some extent, by evolutionarily conserved nutrient sensing pathways (e.g. the insulin/IGF-1-signaling, mTOR, AMPK, and sirtuins) from worms to humans. These pathways are also commonly involved in carcinogenesis and cancer metabolism. Agents (e.g. metformin, resveratrol, and Rhodiola) that target these nutrient sensing pathways often have both anti-aging and anti-cancer efficacy. These agents not only reprogram energy metabolism of malignant cells, but also target normal postmitotic cells by suppressing their conversion into senescent cells, which confers systematic metabolism benefits. These agents are fundamentally different from chemotherapy (e.g. paclitaxel and doxorubicin) or radiation therapy that causes molecular damage (e.g. DNA and protein damages) and thereby no selection resistance may be expected. By reviewing molecular mechanisms of action, epidemiological evidence, experimental data in tumor models, and early clinical study results, this review provides information supporting the promising use of agents with both anti-aging and anti-cancer efficacy for cancer chemoprevention.

Citing Articles

Yeast cells experience chronological life span extension under prolonged glucose starvation.

Mallick S, Shormi A, Jahan H, Alam M, Begum R, Sarker R Heliyon. 2025; 11(4):e42898.

PMID: 40070955 PMC: 11894305. DOI: 10.1016/j.heliyon.2025.e42898.


Skin Cancer Microenvironment: What We Can Learn from Skin Aging?.

DArino A, Caputo S, Eibenschutz L, Piemonte P, Buccini P, Frascione P Int J Mol Sci. 2023; 24(18).

PMID: 37762344 PMC: 10531546. DOI: 10.3390/ijms241814043.


Phenolic Compounds of L. as the Potential Alternative Therapy in the Treatment of Chronic Diseases.

Bernatoniene J, Jakstas V, Kopustinskiene D Int J Mol Sci. 2023; 24(15).

PMID: 37569669 PMC: 10418374. DOI: 10.3390/ijms241512293.


Anti-aging Strategies and Topical Delivery of Biopolymer-based Nanocarriers for Skin Cancer Treatment.

Ramaraj J, Narayan S Curr Aging Sci. 2023; 17(1):31-48.

PMID: 36941817 DOI: 10.2174/1874609816666230320122018.


Metformin treatment reduces motor and neuropsychiatric phenotypes in the zQ175 mouse model of Huntington disease.

Sanchis A, Garcia-Gimeno M, Canada-Martinez A, Sequedo M, Millan J, Sanz P Exp Mol Med. 2019; 51(6):1-16.

PMID: 31165723 PMC: 6549163. DOI: 10.1038/s12276-019-0264-9.


References
1.
Higami Y, Tsuchiya T, Chiba T, Yamaza H, Muraoka I, Hirose M . Hepatic gene expression profile of lipid metabolism in rats: Impact of caloric restriction and growth hormone/insulin-like growth factor-1 suppression. J Gerontol A Biol Sci Med Sci. 2006; 61(11):1099-110. DOI: 10.1093/gerona/61.11.1099. View

2.
Lebwohl D, Anak O, Sahmoud T, Klimovsky J, Elmroth I, Haas T . Development of everolimus, a novel oral mTOR inhibitor, across a spectrum of diseases. Ann N Y Acad Sci. 2013; 1291:14-32. DOI: 10.1111/nyas.12122. View

3.
Bayraktar S, Hernadez-Aya L, Lei X, Meric-Bernstam F, Litton J, Hsu L . Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer. Cancer. 2011; 118(5):1202-11. PMC: 3207034. DOI: 10.1002/cncr.26439. View

4.
Howitz K, Bitterman K, Cohen H, Lamming D, Lavu S, Wood J . Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature. 2003; 425(6954):191-6. DOI: 10.1038/nature01960. View

5.
Katona B, Cummins C, Ferguson A, Li T, Schmidt D, Mangelsdorf D . Synthesis, characterization, and receptor interaction profiles of enantiomeric bile acids. J Med Chem. 2007; 50(24):6048-58. DOI: 10.1021/jm0707931. View